| Title : Preclinical evaluation of properties of a new targeted cytotoxic somatostatin analog, AN-162 (AEZS-124), and its effects on tumor growth inhibition - Seitz_2009_Anticancer.Drugs_20_553 |
| Author(s) : Seitz S , Schally AV , Treszl A , Papadia A , Rick F , Szalontay L , Szepeshazi K , Ortmann O , Halmos G , Hohla F , Buchholz S |
| Ref : Anticancer Drugs , 20 :553 , 2009 |
| Abstract : Seitz_2009_Anticancer.Drugs_20_553 |
| ESTHER : Seitz_2009_Anticancer.Drugs_20_553 |
| PubMedSearch : Seitz_2009_Anticancer.Drugs_20_553 |
| PubMedID: 19491659 |
Seitz S, Schally AV, Treszl A, Papadia A, Rick F, Szalontay L, Szepeshazi K, Ortmann O, Halmos G, Hohla F, Buchholz S (2009)
Preclinical evaluation of properties of a new targeted cytotoxic somatostatin analog, AN-162 (AEZS-124), and its effects on tumor growth inhibition
Anticancer Drugs
20 :553
Seitz S, Schally AV, Treszl A, Papadia A, Rick F, Szalontay L, Szepeshazi K, Ortmann O, Halmos G, Hohla F, Buchholz S (2009)
Anticancer Drugs
20 :553